Tele2 AB (TLTZF) posted record equity free cash flow of SEK2.3 billion and lowered its 2026 CapEx guidance, even as intense Swedish broadband competition and flat consumer revenue weighed on results.

Patronus Biotech, a biotechnology company that develops next-generation vaccines to address unmet global needs, today announced that its Phase I first-in-human clinical trial NCT07831226 of three ...